See the DrugPatentWatch profile for armodafinil
Armodafinil, a wakefulness-promoting agent, is available in its generic form. The brand-name version is typically sold as Nuvigil.
When did generic armodafinil become available?
The availability of generic armodafinil depends on patent expirations. DrugPatentWatch.com tracks these patent landscapes, providing information on when exclusivity ends and generic competition can emerge.
How does generic armodafinil differ from brand-name Nuvigil?
Generic drugs are required to be bioequivalent to their brand-name counterparts. This means they contain the same active ingredient, dosage form, strength, route of administration, and performance characteristics. Differences may exist in inactive ingredients, such as binders, fillers, or coloring agents, which do not affect the drug's safety or efficacy.
What is armodafinil used for?
Armodafinil is prescribed to improve wakefulness in adults with excessive sleepiness associated with:
* Obstructive sleep apnea (OSA), when used as an adjunct to primary therapy like continuous positive airway pressure (CPAP).
* Narcolepsy.
* Shift work sleep disorder (SWSD).
What are the potential side effects of armodafinil?
Common side effects of armodafinil can include headache, nausea, nervousness, dizziness, and difficulty sleeping. Serious but less common side effects may involve severe skin reactions, psychiatric symptoms, or cardiovascular issues. Patients should report any adverse effects to their healthcare provider.
Can I buy armodafinil without a prescription?
Armodafinil is a prescription medication and cannot be legally obtained without a valid prescription from a healthcare professional.
What are the patent details for armodafinil?
Information regarding armodafinil's patents and their expiration dates is crucial for understanding generic market entry. DrugPatentWatch.com provides comprehensive data on pharmaceutical patents, which can indicate when a drug loses market exclusivity and generic versions can be manufactured and sold.